Our study showed that the dosages 0.4 and 0.8 mg/ml drug concentration of DSS could reduce the level of caspase-3 protein in the NRK-52E cells induced by TGF-β1, suggesting that DSS may improve renal fibrosis by reducing apoptosis. The gene discussed is CASP3; the disease is renal fibrosis.